Binding of Glycosaminoglycans to Leukocytes Using Fluorescent Labeled Gag-Derivatives

[1]  J. Harenberg,et al.  Analysis of heparin binding to human leukocytes using a fluorescein-5-isothiocyanate labeled heparin fragment. , 1996, Cytometry.

[2]  J. Harenberg,et al.  N' alkylamine low molecular mass heparins (LMM-heparin-tyramine and LMM-heparin-tyramine-fitc) exhibit long lasting anticoagulant effects. , 1995, Thrombosis research.

[3]  G. Torri,et al.  Synthesis of a N'-alkylamine anticoagulant active low-molecular-mass heparin for radioactive and fluorescent labeling. , 1994, Analytical biochemistry.

[4]  A. Wunder,et al.  Altered pharmacokinetic properties of a lipophilically derivatized low-molecular-weight heparin in rats. , 1993, The Journal of laboratory and clinical medicine.

[5]  K. Ley,et al.  Fucoidin, but not yeast polyphosphomannan PPME, inhibits leukocyte rolling in venules of the rat mesentery. , 1993, Blood.

[6]  R. Dziarski.  Synergistic enhancement of T cell responses and interleukin-1 receptor expression by interleukin-1 and heparin or dextran sulfate. , 1992, Cellular immunology.

[7]  A. Wunder,et al.  Hepatic uptake of a modified low molecular weight heparin in rats. , 1992, The Journal of clinical investigation.

[8]  R L Jackson,et al.  Glycosaminoglycans: molecular properties, protein interactions, and role in physiological processes. , 1991, Physiological reviews.

[9]  R. Dziarski.  Enhancement of mixed leukocyte reaction and cytotoxic antitumor responses by heparin. , 1989, Journal of immunology.

[10]  M. Scully,et al.  Influence of Whole Blood on Standard Curve for Heparin Measurement - Possible Heparin Binding by Red Cells , 1989, Thrombosis and Haemostasis.

[11]  L. Leung,et al.  Heparin binds to human monocytes and modulates their procoagulant activities and secretory phenotypes. Effects of histidine-rich glycoprotein. , 1989, Blood.

[12]  L. Needham,et al.  Endothelial functional responses and increased vascular permeability induced by polycations. , 1988, Laboratory investigation; a journal of technical methods and pathology.

[13]  S. Marklund,et al.  Isolation and sequence of complementary DNA encoding human extracellular superoxide dismutase. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[14]  E. Butcher,et al.  Leukocyte-endothelial cell recognition: evidence of a common molecular mechanism shared by neutrophils, lymphocytes, and other leukocytes. , 1987, Journal of immunology.

[15]  M. W. Peterson,et al.  Cationic neutrophil proteins increase transendothelial albumin movement. , 1987, Journal of applied physiology.

[16]  E. Butcher,et al.  Receptors involved in lymphocyte homing: relationship between a carbohydrate-binding receptor and the MEL-14 antigen , 1987, The Journal of cell biology.

[17]  P. Bornstein,et al.  Control of smooth muscle cell growth by components of the extracellular matrix: autocrine role for thrombospondin. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[18]  M. Petitou,et al.  Endothelial binding sites for heparin. Specificity and role in heparin neutralization. , 1986, The Biochemical journal.

[19]  D. Atha,et al.  Cloned bovine aortic endothelial cells synthesize anticoagulantly active heparan sulfate proteoglycan. , 1986, The Journal of biological chemistry.

[20]  R. Ross.  The pathogenesis of atherosclerosis--an update. , 1986, The New England journal of medicine.

[21]  C. Parish,et al.  Modification of lymphocyte migration by sulfated polysaccharides , 1986, European journal of immunology.

[22]  D. Woolley,et al.  Mast-cell products and heparin stimulate the production of mononuclear-cell factor by cultured human monocyte/macrophages. , 1985, The Biochemical journal.

[23]  J. Harlan.  Leukocyte-endothelial interactions. , 1985, Blood.

[24]  B. Ternai,et al.  Synthetic inhibitors of human leukocyte elastase Part 1--Sulphated polysaccharides. , 1985, Biochemistry international.

[25]  M. De,et al.  An x‐ray diffraction study of lattice imperfections in cold‐worked face‐centered‐cubic alloys. VI. Copper‐aluminum (α phase) , 1984 .

[26]  D. Beeler,et al.  Structural determinants of the capacity of heparin to inhibit the proliferation of vascular smooth muscle cells , 1984, Journal of cellular physiology.

[27]  D. Rylatt,et al.  Demonstration of lymphocyte surface lectins that recognize sulphated polysaccharides. , 1984, Journal of cell science.

[28]  C. Glabe,et al.  Preparation and properties of fluorescent polysaccharides. , 1983, Analytical biochemistry.

[29]  S. Rosen,et al.  Possible role for cell-surface carbohydrate-binding molecules in lymphocyte recirculation , 1983, The Journal of cell biology.

[30]  J. Harenberg,et al.  CHARACTERIZATION OF HEPARINS BY HIGH-PERFORMANCE SIZE EXCLUSION LIQUID CHROMATOGRAPHY , 1983 .

[31]  I. Macgregor,et al.  Heparin receptors on mouse macrophages. , 1983, Thrombosis research.